IN THIS ARTICLE

Citations

1. Van der Linden S, et al. (2009). Ankylosing spondylitis. In GS Firestein et al., eds., Kelley's Textbook of Rheumatology, 8th ed., vol. 2, pp. 1169–1189. Philadelphia: Saunders Elsevier.

Other Works Consulted

• Braun J, et al. (2011). 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Annals of the Rheumatic Diseases, 70(6): 896–904.

• Braun J, Sieper J (2004). Biological therapies in spondyloarthritides—The current state. Rheumatology, 43(9): 1072–1084.

• Braverman SE (2008). Ankylosing spondylitis. In WR Frontera et al., eds., Essentials of Physical Medicine and Rehabilitation, 2nd ed., pp. 605–608. Philadelphia: Saunders Elsevier.

• Gorman JD, et al. (2002). Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor a. New England Journal of Medicine, 346(18): 1349–1356.

• Jaakkola E, et al. (2006). Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Annals of the Rheumatic Diseases, 65(6): 775–780.

• McVeigh CM, Cairns AP (2006). Clinical review: Diagnosis and management of ankylosing spondylitis. BMJ, 333(7568): 581–585.